New Jersey revised its 100-year-old pharmacy practice act to allow pharmacists to administer immunizations and enter collaborative practice agreements to manage drug therapy under protocol.
Iowa Governor Signs Bill Limiting PBM Practices
SF 383 prohibits PBMs from limiting patient choice of pharmacy, unfairly excluding pharmacies from networks, and forces them to reimburse pharmacies no less than what they pay affiliated pharmacies for the same drug.
Pharmacy Law Lowdown: PBM Audit Trends, Enforcement Actions
Dae Lee, PharmD, Esq, CPBS and Lucas Morgan, Esq, discuss PBM and board of pharmacy enforcement actions, trends in PBM audits, and more.
Q&A: Douglas Hoey on How Rite Aid’s Closure Will Impact Independent Pharmacies
Douglas Hoey, CEO of NCPA, discusses what independent pharmacies can do to handle an influx of patients and what the chain’s situation means for the pharmacy landscape.
Podcast: Is The Pharmacy World Prepared For DSCSA?
Todd Eury of the Pharmacy Podcast Network is joined by Josh Bolin of the NABP to talk about DSCSA, what benefits it will provide, and how to make sure your pharmacy is ready when it goes into effect this November.
Bipartisan Bill Aims to Combat PBMs’ Medicaid Spread-Pricing
US Senators on both sides of the aisle came together to announce the Protecting Pharmacies in Medicaid Act.
Medicare Drug Price Negotiations Expose Community Pharmacies to Financial Risk
A survey conducted by 3 Axis Advisors revealed potential impacts of the Inflation Reduction Act’s Medicare Drug Price Negotiation Program.